Loading...
Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis
- Ticker
- CLPT
- Price
- 13.58
- Stock movement up
- +0.03 (0.22%)
- Company name
- Clearpoint Neuro Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Medical Devices
- Market cap
- 403.98M
- Ent value
- 410.24M
- Price/Sales
- 11.77
- Price/Book
- 25.45
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- 10.69%
- 1 year return (CAGR)
- -26.12%
- 3 year return (CAGR)
- 15.65%
- 5 year return (CAGR)
- -12.36%
- 10 year return (CAGR)
- -1.99%
Last updated: 2026-02-20
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
CLPT does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 11.77 |
| Price to Book | 25.45 |
| EV to Sales | 11.95 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 29.75M |
| EPS (TTM) | -0.81 |
| FCF per share (TTM) | -0.49 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 34.33M |
| Gross profit (TTM) | 21.05M |
| Operating income (TTM) | -22.72M |
| Net income (TTM) | -23.14M |
| EPS (TTM) | -0.81 |
| EPS (1y forward) | -0.81 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 61.31% |
| Operating margin (TTM) | -66.19% |
| Profit margin (TTM) | -67.40% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 38.22M |
| Net receivables | 4.00M |
| Total current assets | 51.33M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 8.07M |
| Total assets | 60.36M |
| Accounts payable | 723.00K |
| Short/Current long term debt | 35.74M |
| Total current liabilities | 8.05M |
| Total liabilities | 44.48M |
| Shareholder's equity | 15.87M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -13.09M |
| Capital expenditures (TTM) | 736.00K |
| Free cash flow (TTM) | -13.82M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -145.77% |
| Return on Assets | -38.34% |
| Return on Invested Capital | -50.94% |
| Cash Return on Invested Capital | -30.43% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 13.50 |
| Daily high | 14.01 |
| Daily low | 13.43 |
| Daily Volume | 460K |
| All-time high | 178.00 |
| 1y analyst estimate | 29.00 |
| Beta | 1.02 |
| EPS (TTM) | -0.81 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 4 Mar 2026 |
Downside potential
Loading...
Downside potential data
| CLPT | S&P500 | |
| Current price drop from All-time high | -92.37% | -1.82% |
| Highest price drop | -99.22% | -56.47% |
| Date of highest drop | 21 Sep 2018 | 9 Mar 2009 |
| Avg drop from high | -88.50% | -10.84% |
| Avg time to new high | 214 days | 12 days |
| Max time to new high | 3393 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
403.98M
Marketcap category
Small-cap
Description
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V.; UCB Biopharma SRL; NE Scientific, LLC; and University of California, San Francisco, and Johns Hopkins University. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.
Employees
115
Investor relations
-
SEC filings
CEO
Joseph Michael Burnett
Country
USA
City
Irvine
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page